{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:20:44Z","timestamp":1791328844500,"version":"4.3.1"},"reference-count":64,"publisher":"The Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1,1]]},"DOI":"10.1210\/me.2010-0193","type":"journal-article","created":{"date-parts":[[2010,11,25]],"date-time":"2010-11-25T04:44:45Z","timestamp":1290660285000},"page":"32-43","source":"Crossref","is-referenced-by-count":56,"title":["Identification of Ligand-Selective Peptide Antagonists of the Mineralocorticoid Receptor Using Phage Display"],"prefix":"10.1210","volume":"25","author":[{"given":"Jun","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Medicine (J.Y., P.J.F.), Monash University, Clayton, Victoria 3168, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-yi","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Cancer Biology (C.-y.C., R.S., D.P.M.), Duke University Medical Center, Durham, North Carolina 27710"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachid","family":"Safi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Cancer Biology (C.-y.C., R.S., D.P.M.), Duke University Medical Center, Durham, North Carolina 27710"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Morgan","sequence":"additional","affiliation":[{"name":"Prince Henry\u2019s Institute of Medical Research (J.Y., J.M., P.J.F., C.D.C., M.J.Y.), Clayton, Victoria 3168, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald P.","family":"McDonnell","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Cancer Biology (C.-y.C., R.S., D.P.M.), Duke University Medical Center, Durham, North Carolina 27710"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Fuller","sequence":"additional","affiliation":[{"name":"Department of Medicine (J.Y., P.J.F.), Monash University, Clayton, Victoria 3168, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin D.","family":"Clyne","sequence":"additional","affiliation":[{"name":"Prince Henry\u2019s Institute of Medical Research (J.Y., J.M., P.J.F., C.D.C., M.J.Y.), Clayton, Victoria 3168, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morag J.","family":"Young","sequence":"additional","affiliation":[{"name":"Prince Henry\u2019s Institute of Medical Research (J.Y., J.M., P.J.F., C.D.C., M.J.Y.), Clayton, Victoria 3168, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041122411309000_R1","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cell.2006.06.049","article-title":"Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network.","volume":"126","author":"Bookout","year":"2006","journal-title":"Cell"},{"key":"2019041122411309000_R2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0083-6729(03)01002-1","article-title":"Aldosterone: its receptor, target genes, and actions.","volume":"66","author":"Pearce","year":"2003","journal-title":"Vitam Horm"},{"key":"2019041122411309000_R3","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1096\/fj.06-7970com","article-title":"Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis.","volume":"21","author":"Caprio","year":"2007","journal-title":"FASEB J"},{"key":"2019041122411309000_R4","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1210\/endo-125-4-2224","article-title":"Vascular type I aldosterone binding sites are physiological mineralocorticoid receptors.","volume":"125","author":"Funder","year":"1989","journal-title":"Endocrinology"},{"key":"2019041122411309000_R5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/01.RES.71.3.503","article-title":"Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor.","volume":"71","author":"Lombe\u0300s","year":"1992","journal-title":"Circ Res"},{"key":"2019041122411309000_R6","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1046\/j.1365-2826.2002.00795.x","article-title":"Coregulator proteins and corticosteroid action in the brain.","volume":"14","author":"Meijer","year":"2002","journal-title":"J Neuroendocrinol"},{"key":"2019041122411309000_R7","first-page":"893","article-title":"Mineralocorticoid excess, dietary sodium, and myocardial fibrosis.","volume":"120","author":"Brilla","year":"1992","journal-title":"J Lab Clin Med"},{"key":"2019041122411309000_R8","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1161\/HYPERTENSIONAHA.109.131110","article-title":"Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone\/salt-induced cardiac fibrosis and increased blood pressure.","volume":"54","author":"Rickard","year":"2009","journal-title":"Hypertension"},{"key":"2019041122411309000_R9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S1043-2760(00)00270-8","article-title":"Aldosterone and the heart.","volume":"11","author":"Young","year":"2000","journal-title":"Trends Endocrinol Metab"},{"key":"2019041122411309000_R10","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The randomized aldactone evaluation study. The effect of spironolactone on morbidity and mortality in patients with severe heart failure.","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"2019041122411309000_R11","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"The eplerenone post-acute myocardial infarction heart failure. Survival study. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"2019041122411309000_R12","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa040135","article-title":"Rates of hyperkalemia after publication of the randomized aldactone evaluation study.","volume":"351","author":"Juurlink","year":"2004","journal-title":"N Engl J Med"},{"key":"2019041122411309000_R13","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0960-0760(03)00200-0","article-title":"Dissecting mineralocorticoid receptor structure and function.","volume":"85","author":"Rogerson","year":"2003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122411309000_R14","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1046\/j.1523-1755.2000.00958.x","article-title":"Mechanistic aspects of mineralocorticoid receptor activation.","volume":"57","author":"Hellal-Levy","year":"2000","journal-title":"Kidney Int"},{"issue":"Pt 1","key":"2019041122411309000_R15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1042\/bj3020191","article-title":"Differential intracellular localization of human mineralocorticosteroid receptor on binding of agonists and antagonists","volume":"302","author":"Lombes","year":"1994","journal-title":"Biochem J"},{"key":"2019041122411309000_R16","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1101\/gad.12.21.3343","article-title":"Structure and specificity of nuclear receptor-coactivator interactions.","volume":"12","author":"Darimont","year":"1998","journal-title":"Gene Dev"},{"key":"2019041122411309000_R17","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/42750","volume":"387","author":"Heery","journal-title":"Nature"},{"key":"2019041122411309000_R18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/47069","article-title":"The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors.","volume":"402","author":"Hu","year":"1999","journal-title":"Nature"},{"key":"2019041122411309000_R19","doi-asserted-by":"crossref","first-page":"6056","DOI":"10.1073\/pnas.80.19.6056","article-title":"Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity.","volume":"80","author":"Krozowski","year":"1983","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122411309000_R20","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/med.2610110604","article-title":"Mineralocorticoid receptor ligands: biochemical, pharmacological, and clinical aspects.","volume":"11","author":"Sutanto","year":"1991","journal-title":"Med Res Rev"},{"key":"2019041122411309000_R21","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0140-6736(88)90742-8","article-title":"Localisation of 11\u03b2-hydroxysteroid dehydrogenase\u2014tissue specific protector of the mineralocorticoid receptor.","volume":"2","author":"Edwards","year":"1988","journal-title":"Lancet"},{"key":"2019041122411309000_R22","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1126\/science.2845584","article-title":"Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated.","volume":"242","author":"Funder","year":"1988","journal-title":"Science"},{"key":"2019041122411309000_R23","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1016\/0303-7207(94)90176-7","article-title":"Cloning and tissue distribution of the human 11\u03b2-hydroxysteroid dehydrogenase type 2 enzyme","volume":"105","author":"Albiston","year":"1994","journal-title":"Mol Cell Endocrinol"},{"key":"2019041122411309000_R24","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1210\/endo.136.10.7664690","article-title":"Cloning of the mouse 11\u03b2-hydroxysteroid dehydrogenase type 2 gene: tissue specific expression and localization in distal convoluted tubules and collecting ducts of the kidney.","volume":"136","author":"Cole","year":"1995","journal-title":"Endocrinology"},{"key":"2019041122411309000_R25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.RES.0000080521.15238.E5","article-title":"Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure.","volume":"93","author":"Qin","year":"2003","journal-title":"Circ Res"},{"key":"2019041122411309000_R26","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/HYPERTENSIONAHA.108.114223","article-title":"Corticosteroids and redox potential modulate spontaneous contractions in isolated rat ventricular cardiomyocytes.","volume":"52","author":"Rossier","year":"2008","journal-title":"Hypertension"},{"key":"2019041122411309000_R27","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1042\/CS20080247","article-title":"Mediators of mineralocorticoid receptor-induced profibrotic inflammatory responses in the heart.","volume":"116","author":"Wilson","year":"2009","journal-title":"Clin Sci"},{"key":"2019041122411309000_R28","doi-asserted-by":"crossref","first-page":"F181","DOI":"10.1152\/ajprenal.2001.280.2.F181","article-title":"Multiple aspects of mineralocorticoid selectivity","volume":"280","author":"Farman","year":"2001","journal-title":"Am J Physiol-Renal"},{"key":"2019041122411309000_R29","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1210\/endo.135.3.8070376","article-title":"The mineralocorticoid receptor discriminates aldosterone from glucocorticoids independently of the 11\u03b2-hydroxysteroid dehydrogenase.","volume":"135","author":"Lombes","year":"1994","journal-title":"Endocrinology"},{"key":"2019041122411309000_R30","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/me.2009-0032","article-title":"Structural and functional characterization of the interdomain interaction in the mineralocorticoid receptor.","volume":"23","author":"Pippal","year":"2009","journal-title":"Mol Endocrinol"},{"key":"2019041122411309000_R31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0303-7207(02)00413-6","article-title":"Interdomain interactions in the mineralocorticoid receptor.","volume":"200","author":"Rogerson","year":"2003","journal-title":"Mol Cell Endocrinol"},{"key":"2019041122411309000_R32","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.molcel.2007.08.012","article-title":"Nuclear receptor coregulators: judges, juries, and executioners of cellular regulation.","volume":"27","author":"Lonard","year":"2007","journal-title":"Mol Cell"},{"key":"2019041122411309000_R33","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.cell.2006.04.021","article-title":"The expanding cosmos of nuclear receptor coactivators.","volume":"125","author":"Lonard","year":"2006","journal-title":"Cell"},{"key":"2019041122411309000_R34","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/39645","article-title":"Molecular basis of agonism and antagonism in the oestrogen receptor.","volume":"389","author":"Brzozowski","year":"1997","journal-title":"Nature"},{"key":"2019041122411309000_R35","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1126\/science.285.5428.744","article-title":"Peptide antagonists of the human estrogen receptor.","volume":"285","author":"Norris","year":"1999","journal-title":"Science"},{"key":"2019041122411309000_R36","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1126\/science.1068537","article-title":"Molecular determinants for the tissue specificity of SERMs.","volume":"295","author":"Shang","year":"2002","journal-title":"Science"},{"key":"2019041122411309000_R37","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0092-8674(00)81717-1","article-title":"The structural basis of estrogen receptor\/coactivator recognition and the antagonism of this interaction by tamoxifen.","volume":"95","author":"Shiau","year":"1998","journal-title":"Cell"},{"key":"2019041122411309000_R38","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1210\/mend.16.4.0818","article-title":"Evaluation of ligand-dependent changes in AR structure using peptide probes.","volume":"16","author":"Chang","year":"2002","journal-title":"Mol Endocrinol"},{"key":"2019041122411309000_R39","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1128\/MCB.20.9.3102-3115.2000","article-title":"The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding.","volume":"20","author":"Giangrande","year":"2000","journal-title":"Mol Cell Biol"},{"key":"2019041122411309000_R40","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1210\/me.2005-0309","article-title":"Linking ligand-induced alterations in androgen receptor structure to differential gene expression: a first step in the rational design of selective androgen receptor modulators.","volume":"20","author":"Kazmin","year":"2006","journal-title":"Mol Endocrinol"},{"key":"2019041122411309000_R41","doi-asserted-by":"crossref","first-page":"7940","DOI":"10.1073\/pnas.122225699","article-title":"Coactivator\/corepressor ratios modulate PR-mediated transcription by the selective receptor modulator RU486.","volume":"99","author":"Liu","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122411309000_R42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1677\/JME-09-0031","article-title":"The mineralocorticoid receptor and its coregulators.","volume":"43","author":"Yang","year":"2009","journal-title":"J Mol Endocrinol"},{"key":"2019041122411309000_R43","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1210\/me.2004-0537","article-title":"The ligand-dependent interaction of mineralocorticoid receptor with coactivator and corepressor peptides suggests multiple activation mechanisms.","volume":"19","author":"Hultman","year":"2005","journal-title":"Mol Endocrinol"},{"key":"2019041122411309000_R44","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.molcel.2005.06.026","article-title":"Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor.","volume":"19","author":"Li","year":"2005","journal-title":"Mol Cell"},{"key":"2019041122411309000_R45","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0960-0760(03)00262-0","article-title":"Full-length estrogen receptor \u03b1 and its ligand-binding domain adopt different conformations upon binding ligand.","volume":"86","author":"Bapat","year":"2003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041122411309000_R46","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1128\/MCB.22.11.3698-3706.2002","article-title":"Ligand-selective potentiation of rat mineralocorticoid receptor activation function 1 by a CBP-containing histone acetyltransferase complex.","volume":"22","author":"Kitagawa","year":"2002","journal-title":"Mol Cell Biol"},{"key":"2019041122411309000_R47","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1124\/mol.65.3.761","article-title":"DAXX, FLASH, and FAF-1 modulate mineralocorticoid and glucocorticoid receptor-mediated transcription in hippocampal cells: toward a basis for the opposite actions elicited by two nuclear receptors?","volume":"65","author":"Obradovic\u0301","year":"2004","journal-title":"Mol Pharmacol"},{"key":"2019041122411309000_R48","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1210\/me.2004-0331","article-title":"The elongation factor ELL (eleven-nineteen lysine-rich leukemia) is a selective coregulator for steroid receptor functions.","volume":"19","author":"Pascual-Le Tallec","year":"2005","journal-title":"Mol Endocrinol"},{"key":"2019041122411309000_R49","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1210\/me.2003-0299","article-title":"Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: implication of small ubiquitin-related modifier 1 modification.","volume":"17","author":"Tallec","year":"2003","journal-title":"Mol Endocrinol"},{"key":"2019041122411309000_R50","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1210\/mend.15.9.0689","article-title":"A new human MR splice variant is a ligand-independent transactivator modulating corticosteroid action.","volume":"15","author":"Zennaro","year":"2001","journal-title":"Mol Endocrinol"},{"key":"2019041122411309000_R51","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0076-6879(03)64007-3","article-title":"Application of random peptide phage display to the study of nuclear hormone receptors.","volume":"364","author":"Chang","year":"2003","journal-title":"Methods Enzymol"},{"key":"2019041122411309000_R52","doi-asserted-by":"crossref","first-page":"23691","DOI":"10.1074\/jbc.M211908200","article-title":"The use of phage display technique for the isolation of androgen receptor interacting peptides with (F\/W)XXL(F\/W) and FXXLY new signature motifs.","volume":"278","author":"Hsu","year":"2003","journal-title":"J Biol Chem"},{"key":"2019041122411309000_R53","doi-asserted-by":"crossref","first-page":"8226","DOI":"10.1128\/MCB.19.12.8226","article-title":"Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors \u03b1 and \u03b2.","volume":"19","author":"Chang","year":"1999","journal-title":"Mol Cell Biol"},{"key":"2019041122411309000_R54","first-page":"605","article-title":"Selection of estrogen receptor \u03b2- and thyroid hormone receptor \u03b2-specific coactivator-mimetic peptides using recombinant peptide libraries.","volume":"14","author":"Northrop","year":"2000","journal-title":"Mol Endocrinol"},{"key":"2019041122411309000_R55","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.mce.2008.11.030","article-title":"Purification and characterization of recombinant human mineralocorticoid receptor.","volume":"302","author":"Clyne","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"2019041122411309000_R56","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1210\/me.2007-0201","article-title":"The nuclear receptor-coactivator interaction surface as a target for peptide antagonists of the peroxisome proliferator-activated receptors.","volume":"21","author":"Mettu","year":"2007","journal-title":"Mol Endocrinol"},{"key":"2019041122411309000_R57","doi-asserted-by":"crossref","first-page":"11762","DOI":"10.1158\/0008-5472.CAN-05-2792","article-title":"Coactivation of liver receptor homologue-1 by peroxisome proliferator-activated receptor \u03b3 coactivator-1\u03b1 on aromatase promoter II and its inhibition by activated retinoid X receptor suggest a novel target for breast-specific antiestrogen therapy.","volume":"65","author":"Safi","year":"2005","journal-title":"Cancer Res"},{"key":"2019041122411309000_R58","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.chembiol.2009.01.016","article-title":"Differential presentation of protein interaction surfaces on the androgen receptor defines the pharmacological actions of bound ligands.","volume":"16","author":"Norris","year":"2009","journal-title":"Chem Biol"},{"key":"2019041122411309000_R59","first-page":"2010","article-title":"Development of peptide antagonists that target estrogen receptor \u03b2-coactivator interactions.","volume":"14","author":"Hall","year":"2000","journal-title":"Mol Endocrinol"},{"key":"2019041122411309000_R60","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1083\/jcb.148.6.1177","article-title":"Gemin4. A novel component of the SMN complex that is found in both gems and nucleoli.","volume":"148","author":"Charroux","year":"2000","journal-title":"J Cell Biol"},{"key":"2019041122411309000_R61","first-page":"2917","article-title":"Circumventing tamoxifen resistance in breast cancers using antiestrogens that induce unique conformational changes in the estrogen receptor.","volume":"61","author":"Connor","year":"2001","journal-title":"Cancer Res"},{"key":"2019041122411309000_R62","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1046\/j.1523-1755.2000.00983.x","article-title":"Mineralocorticoid receptor antagonists: the evolution of utility and pharmacology.","volume":"57","author":"Delyani","year":"2000","journal-title":"Kidney Int"},{"key":"2019041122411309000_R63","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1440-1681.2004.04079.x","article-title":"Differences in the determinants of eplerenone, spironolactone and aldosterone binding to the mineralocorticoid receptor.","volume":"31","author":"Rogerson","year":"2004","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2019041122411309000_R64","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.molcel.2006.10.012","article-title":"Receptor-selective coactivators as tools to define the biology of specific receptor-coactivator pairs.","volume":"24","author":"Gaillard","year":"2006","journal-title":"Mol Cell"}],"container-title":["Molecular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mend\/article-pdf\/25\/1\/32\/10721282\/mend0032.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T17:38:28Z","timestamp":1555090708000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mend\/article\/25\/1\/32\/2623155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,1]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1,1]]}},"URL":"https:\/\/doi.org\/10.1210\/me.2010-0193","relation":{},"ISSN":["0888-8809","1944-9917"],"issn-type":[{"value":"0888-8809","type":"print"},{"value":"1944-9917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,1]]}}}